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Impaired K regulation contributes to exercise limitation in ing incremental exercise testing, reaching only 50 to 60%
end-stage renal failure. of healthy control levels [reviewed in 1]. It is likely that
Background. Patients with end-stage renal failure (ESRF) impairments in muscle O2 delivery, due to anemia [2–4],exhibit grossly impaired maximal exercise performance. This
depressed muscle blood flow [5] and capillary rarefactionstudy investigated whether K regulation during exercise is
[6], contribute to the depressed V˙O2 peak during exerciseimpaired in ESRF and whether this is related to reduced exer-
cise performance. in ESRF. However, improvements in V˙O2 peak with
Methods. Nine stable hemodialysis patients and eight con- epoetin (EPO) are considerably less than expected from
trols (CON) performed incremental cycling exercise to voli- increases in hemoglobin concentration ([Hb]) [1, 2, 5],
tional fatigue, with measurement of peak oxygen consumption
while normalization of [Hb] to 14 g · dL1 with EPO in(V˙O2 peak). Arterial blood was sampled during and following
ESRF does not restore normal V˙O2 peak values [7]. Inexercise and analyzed for plasma [K] (PK).
Results. The V˙O2 peak was approximately 44% less in ESRF addition, muscle mitochondrial O2 utilization probably
than in CON (P 0.001), whereas peak exercise PK was greater is reduced also, as indicated by abnormalities in mito-
(7.23 0.38 vs. 6.23 0.14 mmol · L1, respectively, P 0.001). chondrial structure [8] and impaired post-contractile
In ESRF, the rate of rise in PK during exercise was twofold metabolic recovery [6]. Thus, numerous factors in thegreater (0.43  0.05 vs. 0.23  0.03 mmol · L1 ·min1, P 
oxygen transport and utilization chain may limit exercise0.005) and the ratio of rise in PK relative to work performed
performance in ESRF, but additional factors are alsowas 3.7-fold higher (90.1  13.5 vs. 24.7  3.3 nmol · L1 · J1,
P  0.001). A strong inverse relationship was found between important.
V˙O2 peak and the PK · work1 ratio (r  0.80, N  17, P  Muscle fatigue is consistently reported as a major or
0.001). sole subjective factor causing exercise termination inConclusions. Patients with ESRF exhibit grossly impaired
ESRF [7, 9]. The mechanisms of fatigue are multifacto-extrarenal K regulation during exercise, demonstrated by an
rial, but include disturbances in muscle sodium ([Na])excessive rise in PK relative to work performed. We further show
that K regulation during exercise was correlated with aerobic and potassium ([K]) concentrations and reduced maxi-
exercise performance. These results suggest that disturbed K mal muscle Na,K-ATPase activity [10, 11]. In ESRF,
regulation in ESRF contributes to early muscle fatigue during recent evidence is suggestive of defective muscle Na
exercise, thus causing reduced exercise performance.
and K regulation, suggesting a link with increased mus-
cle fatigue. In uremic rats, the skeletal muscle maximal
Na,K-ATPase activity is compromised [12–15]. In hu-
Patients with end-stage renal failure (ESRF) on main- mans, erythrocytic Na,K-ATPase activity also is re-
tenance hemodialysis typically demonstrate markedly re- duced in uremia [16, 17], with membrane depolarization
duced peak pulmonary oxygen uptake (V˙O2 peak) dur- evident in resting skeletal muscle, together with an ele-
vated or labile myocytic intracellular [Na] [18–20]. Im-
paired muscle Na,K-ATPase activity in ESRF, throughKey words: fatigue, extrarenal potassium, aerobic exercise, hemodialy-
sis, pulmonary oxygen uptake, epoetin, hemoglobin. excessive increases in myocytic intracellular [Na] and
extracellular [K] during exercise, may result in early-Received for publication November 15, 2001
onset muscle fatigue.and in revised form August 8, 2002
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plasma [K] (PK) are often used as a marker of K Incremental exercise test
regulation [11, 22–24]. Few studies have measured PK All subjects reported to the laboratory in the after-
during exercise in ESRF and these all suffer major meth- noon at least two hours after a light meal and confirmed
odological limitations. Several studies have lacked com- that they had not performed strenuous physical activity
parable controls [7, 9, 25, 26], which preclude identifica- in the previous 24 hours, nor taken caffeine or nicotine
tion of any abnormal PK responses. Another study failed in the two hours prior to the exercise test. The test was
to detect the usual significant performance deficit in performed from 6 to 42 hours after their last dialysis
ESRF [27]. Methodological flaws in blood sampling in- session (27.3 13.1 h, mean SD). Heart rate (HR) and
validate findings in several studies. Collection of blood
rhythm were monitored using a 12-lead electrocardiogram
samples following cessation of exercise [28] underesti-
(Mortara, Boston, MA, USA). Subjects sat on an electri-mates the peak exercise PK due to the rapid post-exercise cally braked cycle ergometer (Lode, Groningen, Hol-decline that occurs in PK [22, 24]. Measurement of PK in land) for 15 minutes before commencing pedaling at 25 W,venous blood antecubital [27, 29] may underestimate PK
with progressive increments of 25 W each minute. Theduring low intensity leg exercise due to extraction of K
pedal cadence was 70 rpm and the test was continuedby inactive forearm muscle [30]. In contrast, during high
until volitional fatigue, defined as an inability to maintainintensity leg exercise, such as at the V˙O2 peak [27], ante-
pedal cadence above 55 rpm. Mixed expired O2 and CO2cubital venous sampling may exaggerate PK due to K
fractions were continuously measured during exercise byrelease from contracting forearm muscles [11]. The limi-
rapidly responding analyzers (Ametek S-3A/II; Ametektations in each of these studies and the possible impor-
CD-3A, Pittsburgh, PA, USA), with expired volume de-tance of defective muscle K regulation in exercise limi-
termined using a flow transducer (K520; KL Engi-tation make it important to clarify whether arterial K
neering, Sylmar, CA, USA). The V˙O2 was calculated andregulation during exercise is abnormal in ESRF. There-
displayed (Turbofit, Vacumetrics, Ventura, CA, USA)fore, to our knowledge for the first time, we measured
every 15 seconds on a personal computer. The gas ana-PK in arterial blood, sampled during exercise, at well-
lyzers and ventilometer were calibrated before and re-controlled work rates, and compared this to the PK re-
sponses during exercise in a matched control group. We checked after each test with precision reference gases
tested two hypotheses: (1) that patients with ESRF and a standard syringe, respectively.
would display an abnormally elevated arterial PK during
Blood sampling and analysesand following incremental exercise compared to control
subjects; and (2) that altered K regulation is related to A 16G needle (Kawasumi Laboratories, Tokyo, Ja-
impaired V˙O2 peak. pan) was inserted into the arterial side of the forearm
arteriovenous fistula, allowing sampling of arterial blood
in the ESRF patients. In CON, a catheter (Jelco 20GMETHODS
or 22G) was inserted into a radial artery under localSubjects
anesthesia (2% lignocaine injection). Resting blood sam-
All subjects gave written informed consent. All proce- ples were obtained after the subject had been seated for
dures were approved by the Victoria University of Tech- 12 minutes on the cycle ergometer. Subsequent blood
nology Human Research Ethics Committee and the Royal samples were drawn during the last 15 seconds of each
Melbourne Hospital Board of Medical Research Advi-
minute of incremental exercise, at the point of fatigue
sory Committee. Nine young untrained patients (5 males,
and at 1, 2, 5, 10, 20 and 30 minutes post-exercise, with4 females) with ESRF with no cardiovascular, respiratory
subjects maintaining their seated posture. The totalor skeletal muscle disease and eight (4 males, 4 females)
quantity of blood withdrawn was approximately 75 mL.healthy, untrained, age-matched subjects participated as
Blood samples were analyzed in duplicate for PK (Cibacontrols (CON). No significant differences were found
Corning 865, Essex, UK) and [Hb] (Radiometer OSM2;between the groups (mean  SD) for age (ESRF 25.8 
Radiometer, Copenhagen, Denmark), and in triplicate4.1 vs. CON 24.3  6.1 years), height (ESRF 169.3  6.7
for hematocrit (Hct) using heparinized micro-hematocritvs. CON 171.2 7.7 cm) or body mass (ESRF 69.4 16.7
tubes centrifuged for four minutes at 13,000 rpm. Ana-vs. CON 67.0 7.7 kg). The patients had received regular
lyzers were calibrated immediately before and during thehemodialysis treatment for periods of 18 to 58 months
analyses with precision standards. Calculations for the(34.3  12.5 months, mean  SD). Causes of ESRF
percentage decline in plasma volume from resting condi-included glomerulonephritis (N 6), reflux nephropathy
tions (PV), the ratio of rise in PK at peak exercise relative(N 2) and Alport syndrome (N 1). Six patients were
to total work output (PK · work1, nmol · L1 · J1),treated for hypertension with an angiotensin-converting
and the correction of PK for the decline in PV were asenzyme (ACE) inhibitor and/or a Ca2 channel blocker,
while four patients were receiving treatment with epoetin. previously described [10, 22, 31].
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Fig. 1. Oxygen consumption (V˙O2) at common submaximal and at
peak work rates during incremental cycle exercise, in patients with end-
stage renal failure (; ESRF, N  9) and in healthy controls (; CON,
N  8). Data are presented as mean  SEM. ***ESRF  CON, P 
0.05; #slope of the V˙O2 – work rate relationship, ESRF  CON, P 
0.005.
Total blood volume
For patients with ESRF, Hb mass was measured, and
blood volume (BV) and plasma volume (PV) then de-
rived, using the carbon monoxide (CO) rebreathing tech-
nique [32]. Patients were seated for 20 minutes prior to Fig. 2. Change in plasma volume during and following incremental
this estimation. Tests were conducted two days prior to cycle exercise (A ) and during exercise expressed as a proportion of
V˙O2 peak (B ), for patients with ESRF (; N  9) and healthy controlsthe exercise test and at the same time of day and interval
(; N  8). Data are mean  SEM. *PV, ESRF  CON, P  0.05.from dialysis. For control subjects, resting BV and PV
were assumed equivalent to results previously obtained
using the same technique, in a group of healthy controls ESRF 24.5  2.3 vs. CON 43.7  1.5 mL · kg1 · min1)
of similar age, size and gender in our laboratory (ab- than CON (Fig. 1). The slope of the linear relationship
stract; Haukka et al, Clin Sci 87:176, 1994) [32]. The rise between the submaximal V˙O2 and work rate was less in
in arterial K content (mmol) with peak exercise was ESRF (ESRF 0.12  0.01 vs. CON 0.15  0.01 mL · J1,
calculated from the product of PK and PV, after correct- P  0.005; Fig. 1). The heart rate in ESRF was higher
ing for the calculated decline in PV with exercise. at rest (ESRF 94  4 vs. CON 77  5 beats · min1)
and at all common submaximal work rates (25 to 100 WStatistical analyses
inclusive, P  0.05), but was lower at peak exercise
Results are reported as mean  SEM, with P  0.05 compared with CON (ESRF 168  7 vs. CON 181  3
accepted for significance. PK at rest, during exercise at beats · min1, P  0.05).
submaximal work rates common for both ESRF and
Hematology and plasma volumeCON (25, 50, 75 and 100 W), at peak exercise and in
recovery for both groups were compared by analysis of In ESRF patients, [Hb] ranged from 6.1 to 9.2 g · dL1
variance (ANOVA) with repeated measures, with post- (ESRF 7.8  0.4 vs. CON 14.3 0.5 g · dL1, P 0.001)
hoc Newman-Keuls analyses. and Hct from 19.6 to 31.1% (ESRF 25.3  1.2 vs. CON
41.3  1.5%, P  0.001). Resting plasma volume (PV)
in ESRF patients was 3.70  0.30 L, or 54.4  5.1 mL ·RESULTS
kg1. This was 32% (L) and 30% (mL · kg1) greater
Exercise performance and oxygen consumption than the PV previously measured for equivalent young,
The reason given for stopping the exercise test was healthy controls, at 2.81  0.17 L, or 41.9  1.4 mL ·
leg fatigue for all ESRF patients, who attained a lower kg1, respectively (abstract; ibid) [32]. The PV declined
progressively with increased exercise intensity, with a(P  0.001) peak work rate (49%) and V˙O2 peak (44%,
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Fig. 4. Rate of the rise in arterial PK and the rise in PK relative to work
done for patients with end-stage renal failure (; N  9) and healthy
controls (; N  8). Data expressed as mean  SEM. ***ESRF 
CON, P  0.001; #ESRF  CON, P  0.005.
Fig. 3. Arterial plasma [K] (PK) at rest, during and following incre-
mental cycle exercise (A ) and the rise in PK during exercise (B ), for
patients with end-stage renal failure (; N  9) and healthy controls
(; N 8). Data are mean SEM. *ESRFCON, P 0.05; φESRF
CON, P  0.005.
greater PV in ESRF evident at 100 W (P  0.05), Fig. 5. Arterial PK expressed as a proportion of V˙O2 peak, for patients
but not at peak exercise (Fig. 2A). The resting PV was with end-stage renal failure (; N  9) and healthy controls (; N  8).
Data are mean  SEM.regained after 10 minutes of recovery in ESRF, but not
until 30 minutes of recovery in CON (Fig. 2A). When
expressed relative to the percentage of the peak exercise
V˙O2, the PV was similar in both groups (Fig. 2B). ESRF than in CON for the first two minutes of recovery
(P  0.05).Arterial plasma potassium concentration and content
The absolute rise in PK above rest (PK) was greaterduring exercise
in ESRF than in CON during exercise at work rates of
Resting arterial PK was approximately 0.9 mmol · L1 50, 75 and 100 W (P  0.05), but was similar at peak
higher in ESRF than in CON (P  0.005; Fig. 3A). PK exercise (ESRF 2.35  0.26 vs. CON 2.25  0.13 mmol ·
increased during exercise in both groups (P  0.001), L1; Fig. 3B). During exercise the rate of rise in PK in
with greater PK found during submaximal and peak exer- ESRF (PK · min1) was twice that of CON (P  0.005),
cise for ESRF than for CON (P  0.05; Fig. 3A). PK at while at peak exercise, the PK · work1 ratio was 3.6-
peak exercise ranged from 5.91 to 8.98 mmol · L1 in fold higher in ESRF (P  0.001; Fig. 4).
ESRF, including 8 mmol · L1 in three patients, and When expressed as a proportion of peak exercise V˙O2,
in CON ranged from 5.72 to 6.92 mmol · L1. PK fell PK remained higher in ESRF at rest and throughout
rapidly after exercise, reaching pre-exercise values by exercise than in CON (Fig. 5), whereas the PK was
two minutes post-exercise; a similar rate of decline over similar for both groups (data not shown). To determine
the initial two-minute recovery period was seen also whether the higher PK during exercise in ESRF might
(ESRF 1.14  0.14 vs. CON 1.00  0.06 mmol · L1 · result from greater hemoconcentration, the PK was cor-
rected for the decline in plasma volume from rest (PV).min1, NS; Fig. 3A). However, PK remained higher in
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mance in ESRF, not simply mediated by an elevated PK,
but rather, reflecting some related associated abnormal-
ity, possibly in muscle K regulation.
When data from the ESRF and controls were pooled
(N  17), a significant association was found between
V˙O2 peak and resting [Hb] (r 0.81, P 0.0001). When
the two groups were considered separately, no significant
relationship was found between V˙O2 peak and resting
[Hb] in either the control or ESRF group.
DISCUSSION
This study investigates abnormalities in PK regulation
during exercise in ESRF and provides two major and
novel findings. We provide clear evidence that arterial
PK is abnormally elevated and K regulation severelyFig. 6. Relationships between V˙O2 peak and the rise in PK relative to
work done for patients with end-stage renal failure (; N  9) and impaired, during and following incremental exercise in
healthy controls (; N  8). Regression lines indicate controls (solid
ESRF, compared to healthy controls. We also show, toline, r  0.73, P  0.05), ESRF (dash-dot line, r  0.50, NS) and
pooled data (dashed line, r0.80, P 0.05). Data are mean SEM. our knowledge for the first time, that K regulation was
related to the maximal incremental exercise performance
(V˙O2 peak). Therefore, it is highly likely that impaired
K regulation in ESRF contributes to their reduced exer-
After correction, PK remained higher in ESRF at all cise performance. This probably reflects deficiencies in
exercise work rates and in recovery compared to controls
skeletal muscle Na and K regulation, which precipitate
(P  0.01) and the corrected PK at peak exercise did muscle fatigue and lead to early exercise cessation.not differ between groups (ESRF 1.27  0.22 vs. CON
1.49  0.10 mmol · L1, NS). Abnormal extrarenal K regulation during
Since the resting absolute PV in ESRF was higher than exercise in ESRF
the value previously determined in controls, changes in
This study provides clear evidence of grossly abnormalthe total plasma K content with exercise also were cal-
arterial PK before, during and following exercise inculated in ESRF and estimated in controls. A similar
ESRF, together with severely compromised maximal ex-rise in PK content at peak exercise was found in both
ercise performance. The higher resting PK in ESRF isgroups (ESRF 4.18  0.90 vs. CON 4.19 mmol). How-
dependent on the time post-dialysis and might be ex-ever, the PK content · work1 ratio at peak exercise was
pected to contribute to the systematically greater PK ob-nearly fourfold higher in ESRF (ESRF 163.09  29.26
served during submaximal and peak exercise and in re-vs. CON, 42.48 nmol · J1), consistent with findings for
covery. However, other factors are clearly importantthe PK · work1 ratio. Therefore, the exaggerated PK
since a greater rise in PK (that is,PK) during submaximalresponse in ESRF relative to work output cannot be
exercise was found in ESRF. Although the PK at peakexplained simply by different fluid volumes at rest or
exercise was similar in ESRF and controls, this occurredduring exercise.
at drastically compromised peak exercise work rates and
Relationships between V˙O2 peak, [Hb] V˙O2 in ESRF. The similar PK at maximal exercise in the
and K variables two groups does not indicate a normal response in ESRF,
since this would imply an identical rate of rise in arterialWhen the ESRF and the control groups were consid-
PK during exercise (PK), as well PK at peak exerciseered separately, a significant inverse relationship was
when normalized for work output (PK · work1 ratio)found between V˙O2 peak and the PK · work1 ratio
in ESRF and controls. Abnormality is evidenced since(Fig. 6) in controls (r  0.73, N  8, P  0.05), but
ESRF patients exhibited a twofold more rapid rate ofnot in ESRF (r  0.50, N  9; NS). When all data
PK and a fourfold higher PK · work1 ratio. The four-were pooled (N  17), a strong inverse relationship was
fold higher PK · work1 ratio in ESRF is much higherfound between V˙O2 peak and the PK work1 ratio (r
than the 22% and 78% higher ratios that can be esti- 0.80, P  0.001; Fig. 6). No significant relationships
mated from data in previous studies [27, 29]. This proba-were found between V˙O2 peak and the peak exercise PK
bly reflects their underestimation of PK due to venousfor either the separate groups or for pooled data (r 
blood sampling and further emphasizes the importance0.34). These findings suggest that impaired K regula-
tion may play a direct role in reduced exercise perfor- of arterial rather than venous blood sampling.
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Possible mechanisms of impaired K regulation during A possible impairment in muscle Na,K-ATPase ac-
tivity most likely would affect all skeletal muscle. Inac-exercise in uremia
tive skeletal muscle plays an important role in plasmaDuring exercise, PK reflects the balance between K
K clearance during exercise [30]. Thus, impaired musclereleased into plasma from contracting muscles and K
Na,K-ATPase activity in ESRF would reduce PK clear-cleared from plasma by other tissues, including inactive
ance by inactive muscle and directly contribute to theskeletal muscle, red blood cells and the kidneys [11,
elevated PK that we have observed. While the role of33–35]. The sharp rise in PK during exercise (Fig. 3)
red blood cells in plasma K clearance during exerciseindicates that K released by contracting skeletal muscle
remains controversial [11, 34, 39], depressed erythrocyticexceeds the PK clearance rate [11]. Thus, greater PK dur-
Na,K-ATPase activity in ESRF [16, 17] also might being exercise in ESRF likely reflects an augmented K
important in impaired PK regulation in ESRF [16, 17].release from contracting muscles. The rate of K release
Therefore, impaired Na,K-ATPase activity in bothfrom contracting muscle is dependent upon the balance
contracting and inactive skeletal muscle in ESRF wouldbetween the rates of cellular K efflux and K re-uptake
both exacerbate muscle K release and directly reduce(which occurs via Na,K-ATPase activity, discussed
PK clearance.later in this article), multiplied by the muscle blood flow
It is likely that the greatly diminished or lack of renal[11, 33]. Cellular K efflux is primarily dependent upon
K clearance in ESRF would make only a very smallmembrane excitation, and thus upon motor unit recruit-
contribution to their exaggerated plasma K responsement [23, 36, 37]. Any absolute submaximal work rate
during exercise. Renal K clearance in healthy controlsrepresents a greater relative intensity (that is, higher %
may double during moderate exercise [35, 40], but thisV˙O2 peak) in ESRF, which would demand increased
effect disappears at higher intensity submaximal exercisemotor unit recruitment and lead to greater cellular K
[35] and K clearance falls during sprint exercise [41].efflux [33]. Interestingly, the PK with exercise in ESRF
However, even a doubling of renal K clearance aboveand controls was similar when exercise intensity was
resting values (1.5 mol · kg1 · min1) [41] representsexpressed relative to peak exercise V˙O2. This indicates
only a minor fraction of the muscle K efflux rates,that the greater rise in PK during exercise in ESRF was
estimated at38 mol · kg1 · min1 during submaximallargely due to their greater relative exercise intensity.
cycling exercise [33]. Thus, extrarenal mechanisms ac-This suggests that an exacerbated muscle K release at
count for almost all of the PK clearance during exercise,very low work rates may be a major factor underlying
and the lack of renal K excretion during exercise cannotthe greater PK response in ESRF. Muscle blood flow is
account for our observation of impaired PK regulationreduced in ESRF [5], which by itself is inconsistent with
with exercise in ESRF. It is possible that the highera hypothesized greater muscle K release (A-V [K]
resting PK in ESRF also may affect the rate of K clear-difference	 flow). However, reductions in skeletal mus-
ance, as shown at rest in a small group of hemodialysiscle blood flow itself may have elevated muscle venous
patients [42]. However, this has not been investigated inK efflux [38]. Thus, reduced blood flow in ESRF does
exercise.not preclude the likelihood of a greater K release from
The elevated PK response in ESRF was only partiallycontracting muscle.
due to a greater hemoconcentration (about 25%), sinceImpaired Na,K-ATPase activity in skeletal muscle
PK remained higher after correction for fluid shifts, atcould reduce K re-uptake in contracting muscle cells
submaximal and peak (12%) exercise work rates, as welland thereby increase venous [K], exacerbate muscle
as in recovery. Finally, chronic deconditioning may con-K release and directly contribute to elevated PK during
tribute to impaired K regulation in ESRF, since thisexercise in ESRF. There are no published data support-
results in an elevated PK · work1 ratio during exerciseing defective skeletal muscle Na,K-ATPase in uremic
[43]. Since training increases the skeletal muscle Na,K-patients. However, 30 to 50% lower maximal in vitro
ATPase content and reduces the PK · work1 ratio dur-muscle Na,K-ATPase activity has been reported in
ing exercise in healthy subjects [31], improved K regula-uremic rats [12–14]. Further, impaired muscle Na,K-
tion also may contribute to the improved exercise perfor-ATPase activity is suggested also by lowered rates of
mance in ESRF after physical conditioning [1].plasma rubidium clearance, in both predialysis and he-
modialysis patients [17]. Such a premise is also entirely
Implications of abnormal K regulation forconsistent with the reported muscle membrane depolar-
muscle fatigueization and disturbed muscle [Na] in uremic patients
These study results show, to our knowledge for the first[18–20] and with impaired erythrocytic Na,K-ATPase
time, a highly significant inverse relationship between theactivity [16, 17]. Consistent with these findings, we have
PK · work1 ratio and V˙O2 peak in the pooled ESRFrecently found muscle Na,K-ATPase activity to be
and control data. Further, we have recently found that39% less in a small group of uremic patients compared
to healthy controls (unpublished data). EPO-induced increases in [Hb] from 10 to 14 g · dL1
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